Coherus Oncology Inc.
CHRS | NASDAQ
$1.33
-$0.04 (-2.92%)
Sep 22, 2026, 11:02 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 82.92M | 115.24M | 88.88M | 103.35M | 216.89M | 82.41M | 125.99M | 97.69M | 159.24M | 259.78M | 102.89M | 80.71M | 73.36M | 16.59M | 63.55M | 286.81M | 275.48M | 325.68M | 417.2M | 360.54M | 329.74M | 259.49M |
Short-Term Investments | 22.38M | 51.81M | 83.25M | 88.31M | 20.74M | n/a | n/a | n/a | n/a | n/a | 14.86M | 50.82M | 71.79M | 111.94M | 128.13M | n/a | n/a | n/a | n/a | 108.17M | 124.68M | 140.01M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 452K | 452K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 11.54M | 13.28M | 4.05M | 4.45M | 5.04M | 5.66M | 50.47M | 78.75M | 57.68M | 74.32M | 77.18M | 86.83M | 71.37M | 72.91M | 84.93M | 87.07M | 86.1M | 69.38M | 65.64M | 56.62M | 66.84M | 62.81M |
Receivables | 14.25M | 22.51M | 18.42M | 250.5M | 119.64M | 62.44M | 122.33M | 198.8M | 313.57M | 284.15M | 260.52M | 216.51M | 141.31M | 101.46M | 109.96M | 91.19M | 115.71M | 117.04M | 123.02M | 136.35M | 141.83M | 140.41M |
Inventory | 5.67M | 4.83M | 3.17M | 2.05M | 4.51M | 3.52M | 70.09M | 47.64M | 62.16M | 61.98M | 62.61M | 66.78M | 63.99M | 49.41M | 38.79M | 27.72M | 31.74M | 36.95M | 37.64M | 37.58M | 39.67M | 51.61M |
Other Current Assets | 5.35M | 9.38M | 6.23M | 8.7M | 11.72M | 154.9M | 11.53M | 14.18M | 13.78M | 14.08M | 11.1M | 15.77M | 17.46M | 20.51M | 22.92M | 21.93M | 16.67M | 19.36M | 10.8M | 10.03M | 8.94M | 10.35M |
Total Current Assets | 133.79M | 206.04M | 206.71M | 460.96M | 380.21M | 310.18M | 341.58M | 369.02M | 557.93M | 627.48M | 475.63M | 444.37M | 385.48M | 315.93M | 381.23M | 448.28M | 446.78M | 512.44M | 602.32M | 673.04M | 660.01M | 617.26M |
Property-Plant & Equipment | 865K | 1.09M | 1.35M | 1.63M | 1.91M | 2.26M | 2.84M | 2.91M | 3.33M | 4.19M | 5.12M | 6.07M | 6.93M | 7.72M | 8.75M | 9.57M | 9.55M | 8M | 7.81M | 8.51M | 9.13M | 9.67M |
Goodwill & Intangibles | 44.99M | 45.61M | 46.24M | 49.48M | 52.31M | 52.98M | 53.65M | 54.31M | 55.46M | 57.1M | 71.67M | 46.52M | 5.81M | 5.87M | 5.93M | 6M | 3.56M | 3.56M | 3.56M | 3.56M | 3.56M | 3.56M |
Total Long-Term Assets | 57.4M | 59.99M | 51.64M | 55.56M | 59.26M | 60.89M | 106.95M | 135.98M | 116.92M | 136.07M | 153.97M | 139.42M | 84.11M | 86.5M | 99.61M | 102.63M | 99.22M | 80.94M | 77.01M | 68.69M | 79.53M | 76.04M |
Total Assets | 191.18M | 266.02M | 258.34M | 516.52M | 439.46M | 371.07M | 448.53M | 505M | 674.86M | 763.55M | 629.6M | 583.78M | 469.59M | 402.43M | 480.85M | 550.91M | 546M | 593.39M | 679.33M | 741.73M | 739.54M | 693.3M |
Account Payables | 13.17M | 11.48M | 9.92M | 24.89M | 37.62M | 40.93M | 28.46M | 21.89M | 76.82M | 38.29M | 35.22M | 37.09M | 29.28M | 23.23M | 11.53M | 9.92M | 17.49M | 21.09M | 16.16M | 45.71M | 14.57M | 15.48M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 1.9M | n/a | n/a | n/a | n/a | n/a | n/a | 2.68M | 175M | n/a | 4.47M | 4.45M | 4.44M | n/a | n/a | n/a | n/a | n/a | 125.28M | 119.01M | 106.99M |
Other Current Liabilities | n/a | 103.67M | 16.07M | 14.88M | 12.51M | 46.25M | 33.11M | 27.14M | 142.74M | 22.76M | 21.52M | 180.01M | 121.58M | 83.32M | 22.61M | n/a | n/a | n/a | 22.01M | 18.79M | 14.82M | 12.09M |
Total Current Liabilities | 75.51M | 132.33M | 141.88M | 373.79M | 265.12M | 255.04M | 282.98M | 295.57M | 463.01M | 538.3M | 331.77M | 239.66M | 169.44M | 123.41M | 138.69M | 171.32M | 140.75M | 153.75M | 165.33M | 320.35M | 287.05M | 257.6M |
Long-Term Debt | 37.25M | 51.52M | 37.05M | 36.96M | 36.87M | 265.35M | 264.93M | 264.51M | 290.06M | 299.67M | 473.37M | 472.77M | 472.19M | 471.62M | 471.06M | 470.5M | 420.97M | 420.46M | 408.28M | 281.9M | 287.08M | 298.04M |
Other Long-Term Liabilities | 16.03M | 1.49M | 15.84M | 14.95M | 14.14M | 30.19M | 28.23M | 28.06M | 632K | 1.63M | 11.46M | 3.51M | 102K | 102K | 3.47M | 102K | 102K | 102K | 750K | 750K | 751K | 750K |
Total Long-Term Liabilities | 54.84M | 55.07M | 55.45M | 54.96M | 54.52M | 299.49M | 297.54M | 297.41M | 295.96M | 307.09M | 491.26M | 477.72M | 474.92M | 475.53M | 479.57M | 476.72M | 427.88M | 427.08M | 416.28M | 290.62M | 296.27M | 308.03M |
Total Liabilities | 130.35M | 187.4M | 197.33M | 428.75M | 319.64M | 554.54M | 580.52M | 592.97M | 758.96M | 845.39M | 823.03M | 717.38M | 644.36M | 598.93M | 618.27M | 648.04M | 568.63M | 580.82M | 581.61M | 610.97M | 583.32M | 565.63M |
Total Debt | 37.71M | 54.37M | 40.34M | 40.69M | 41.03M | 269.93M | 269.9M | 269.88M | 298.34M | 481.16M | 480.84M | 478.68M | 479.26M | 479.86M | 480.42M | 480.72M | 431.76M | 430.34M | 419.02M | 418.77M | 417.94M | 417.56M |
Book Value | 60.84M | 78.62M | 61.01M | 87.77M | 119.83M | -183.47M | -131.99M | -87.97M | -84.11M | -81.84M | -193.43M | -133.6M | -174.76M | -196.51M | -137.42M | -97.13M | -22.63M | 12.56M | 97.73M | 130.76M | 156.22M | 127.67M |
Book Value Per Share | 0.39 | 0.58 | 0.51 | 0.76 | 1.03 | -1.58 | -1.14 | -0.76 | -0.73 | -0.65 | -1.73 | -1.37 | -2 | -2.48 | -1.76 | -1.25 | -0.29 | 0.16 | 1.27 | 1.65 | 2.07 | 1.75 |
Common Stock | 15K | 15K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 11K | 11K | 11K | 9K | 8K | 8K | 7K | 7K | 7K | 7K | 7K | 7K | 7K |
Retained Earnings | -1.44B | -1.42B | -1.38B | -1.35B | -1.31B | -1.61B | -1.55B | -1.5B | -1.49B | -1.48B | -1.58B | -1.5B | -1.46B | -1.42B | -1.34B | -1.28B | -1.2B | -1.15B | -1.05B | -1B | -965.6M | -935.7M |
Comprehensive Income | -281K | -268K | -195K | -203K | -275K | -275K | -275K | -275K | -272K | -272K | -248K | -265K | -297K | -278K | -249K | -270K | -270K | -272K | -270K | -273K | -267K | -307K |
Shareholders Equity | 60.84M | 78.62M | 61.01M | 87.77M | 119.83M | -183.47M | -131.99M | -87.97M | -84.11M | -81.84M | -193.43M | -133.6M | -174.76M | -196.51M | -137.42M | -97.13M | -22.63M | 12.56M | 97.73M | 130.76M | 156.22M | 127.67M |
Total Investments | 22.38M | 51.81M | 83.25M | 88.31M | 20.74M | n/a | n/a | n/a | 452K | 452K | 14.86M | 50.82M | 71.79M | 111.94M | 128.13M | n/a | n/a | n/a | n/a | 108.17M | 124.68M | 140.01M |
Add to Watchlist
Select watchlists to add or remove CHRS